BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12117117)

  • 1. Deslorelin acetate (Ovuplant) therapy in cycling mares: effect of implant removal on FSH secretion and ovarian function.
    Farquhar VJ; McCue PM; Carnevale EM; Nett TM; Squires EL
    Equine Vet J; 2002 Jul; 34(4):417-20. PubMed ID: 12117117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of deslorelin acetate on gonadotropin secretion and ovarian follicle development in cycling mares.
    Farquhar VJ; McCue PM; Nett TM; Squires EL
    J Am Vet Med Assoc; 2001 Mar; 218(5):749-52. PubMed ID: 11280410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares.
    McCue PM; Farquhar VJ; Carnevale EM; Squires EL
    Theriogenology; 2002 Sep; 58(5):865-70. PubMed ID: 12212887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
    Johnson CA; Thompson DL; Cartmill JA
    J Anim Sci; 2003 May; 81(5):1300-7. PubMed ID: 12772858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary responsiveness to GnRH in mares following deslorelin acetate implantation to hasten ovulation.
    Johnson CA; Thompson DL; Cartmill JA
    J Anim Sci; 2002 Oct; 80(10):2681-7. PubMed ID: 12413091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interovulatory intervals in mares receiving deslorelin implants in Ireland (2009 to 2010).
    Henderson IS; Brama P; Osborne M; Beltman ME
    Vet Rec; 2012 May; 170(21):541. PubMed ID: 22535750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictable ovulation in mares treated with an implant of the GnRH analogue deslorelin.
    McKinnon AO; Nobelius AM; del Marmol Figueroa ST; Skidmore J; Vasey JR; Trigg TE
    Equine Vet J; 1993 Jul; 25(4):321-3. PubMed ID: 8354219
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated use of a GnRH analogue deslorelin (Ovuplant) for hastening ovulation in the transitional mare.
    McKinnon AO; Vasey JR; Lescun TB; Trigg TE
    Equine Vet J; 1997 Mar; 29(2):153-5. PubMed ID: 9104567
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of double ovulation in mares using deslorelin acetate.
    Nagao JF; Neves Neto JR; Papa FO; Alvarenga MA; Freitas-Dell'Aqua CP; Dell'Aqua JA
    Anim Reprod Sci; 2012 Dec; 136(1-2):69-73. PubMed ID: 23182475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare.
    Glazar BS; McCue PM; Bruemmer JE; Squires EL
    Theriogenology; 2004 Jul; 62(1-2):57-64. PubMed ID: 15159101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration and timing of fertile ovulation in cyclic mares with a deslorelin implant.
    Gånheim A; Gånheim A; Jöchle W
    Acta Vet Scand; 1995; 36(4):393-400. PubMed ID: 8669367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of deslorelin or hCG administration on reproductive performance in first postpartum estrus mares.
    Blanchar TL; Brinsko SP; Rigby SL
    Theriogenology; 2002 Jul; 58(1):165-9. PubMed ID: 12182359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of BioRelease Deslorelin® injection for induction of ovulation in oestrus mares: a field study.
    Finan SA; Lamkin EL; McKinnon AO
    Aust Vet J; 2016 Sep; 94(9):338-40. PubMed ID: 27569838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen.
    Hemberg E; Lundeheim N; Einarsson S
    Reprod Domest Anim; 2006 Dec; 41(6):535-7. PubMed ID: 17107513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the GnRH analogue, deslorelin acetate, in a slow-release implant to accelerate ovulation in oestrous mares.
    Meyers PJ; Bowman T; Blodgett G; Conboy HS; Gimenez T; Reid MP; Taylor BC; Thayer J; Jöchle W; Trigg TE
    Vet Rec; 1997 Mar; 140(10):249-52. PubMed ID: 9080642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing the time of ovulation in the mare with a short-term implant releasing the GnRH analogue deslorelin.
    Meinert C; Silva JF; Kroetz I; Klug E; Trigg TE; Hoppen HO; Jöchle W
    Equine Vet J; 1993 Jan; 25(1):65-8. PubMed ID: 8422889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive performance of early postpartum Holstein cows where oestrus was synchronised following chronic GnRH agonist treatment.
    Padula AM; MacMillan KL
    Aust Vet J; 2005 Mar; 83(3):163-7. PubMed ID: 15825629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Close synchrony of ovulation in superstimulated heifers that have a downregulated anterior pituitary gland and are induced to ovulate with exogenous LH.
    D'Occhio MJ; Sudha G; Jillella D; Whyte T; Maclellan LJ; Walsh J; Trigg TE; Miller D
    Theriogenology; 1998 Feb; 49(3):637-44. PubMed ID: 10732042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration patterns for luteinising hormone and ovarian function following treatment with GnRH agonist implants (deslorelin) for 7, 14 or 21 days in cycling dairy cows.
    Padula AM; Macmillan KL
    Anim Reprod Sci; 2005 Jun; 87(1-2):11-24. PubMed ID: 15885437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ovulation in nonlactating dairy cows and heifers using different doses of a deslorelin implant.
    Bartolome JA; Santos JE; Pancarci SM; Melendez P; Arteche AC; Hernandez O; Archbald LF; Trigg T; Thatcher WW
    Theriogenology; 2004 Jan; 61(2-3):407-19. PubMed ID: 14662140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.